Innolight's Hong Kong IPO Priced at HK$980, Raising HK$53.4 Billion
Miles Bennett
Innolight (中际旭创) priced its Hong Kong H-share IPO at HK$980 per share, raising HK$53.4 billion (~US$6.8 billion) in the city's largest listing in nearly seven years; yet the pricing sits at a ~21% discount to its Shenzhen A-share, and heavy U.S. revenue dependence plus geopolitical risk remain the key tests post-listing.
How big is this IPO?
Innolight is issuing 54.5 million H-shares at HK$980 each, raising a total of HK$53.4 billion (~US$6.8 billion).
This is Hong Kong's largest new listing since Alibaba's US$12.9 billion secondary listing in 2019.
If the over-allotment option is exercised in full, the deal could reach roughly US$7.8 billion.
This means → even in today's market, the AI hardware trade can support a mega-sized offering — institutions are voting with real capital.
Why is the Hong Kong price so much cheaper than the A-share?
The final price of HK$980 came in below the top of the indicative range (HK$1,010) and at roughly a 21% discount to Innolight's Monday close of RMB 1,076.94 in Shenzhen.
In plain terms = the same company, bought at about an 80% price tag in Hong Kong. The discount is part sweetener for global capital, part the market pricing in geopolitical risk on the H-share side.
Even so, investor indications reached several times the shares on offer, and the company closed its institutional book a day early.
Why is the optical-module business suddenly so profitable?
Innolight's core product is the optical transceiver module — a device that converts electrical signals into light so data-center servers can move data at high speed over fiber.
Q1 2026: net profit nearly tripled year-on-year to RMB 6.32 billion; revenue nearly doubled to RMB 19.5 billion.
This reflects the explosive demand for compute driven by AI model training and inference, transmitting up the chain from chips → optical modules → data centers. Optical modules sit at one of the most direct beneficiary points.
Sixty percent of revenue from the U.S. — how dangerous is that?
In Q1 2026, the U.S. market accounted for 61.7% of the company's revenue — a heavy single-market dependence.
In June this year, Innolight was added to the U.S. Department of Defense's "Chinese Military Companies" list. The company says the designation does not by itself restrict business with U.S. clients or affect its securities trading.
In plain terms = the list is a "label," not a "ban" — for now. But it puts the company under a spotlight: any future escalation in U.S.-China tech restrictions would hit Innolight early and directly.
What will the proceeds be used for?
The company plans to deploy funds across four areas: R&D, global capacity expansion, supply-chain upgrades, and M&A / general working capital.
Lead underwriters include Goldman Sachs, CICC, Morgan Stanley, and GF Securities, with Haitong International, Citi, HSBC, and China Galaxy also on the syndicate.
This means → the company's first priority after listing is to build capacity outside the U.S. and reduce single-market dependence — whether it can deliver on that will determine if the growth trajectory holds.
Content is for reference only, not financial advice.